U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H36O2
Molecular Weight 320.5093
Optical Activity UNSPECIFIED
Defined Stereocenters 9 / 9
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PREGNANDIOL

SMILES

[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)O

InChI

InChIKey=YWYQTGBBEZQBGO-BERLURQNSA-N
InChI=1S/C21H36O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h13-19,22-23H,4-12H2,1-3H3/t13-,14+,15+,16-,17+,18-,19-,20-,21+/m0/s1

HIDE SMILES / InChI

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/mesh/68011276 and http://www.ncbi.nlm.nih.gov/pubmed/9131494

Pregnanediol is a chief steroid metabolite of progesterone that is biologically inactive and occurs as pregnanediol glucuronate in the urine. Pregnanediol has two hydroxyl groups, at 3-alpha and 20-alpha. A test can be done to measure the amount of pregnanediol in urine. The urine test offers an indirect way to measure progesterone levels in the body. It is a standard in the colorimetric determination of urinary pregnanediol in clinical laboratories.

CNS Activity

CNS Active
3913
Curator's Comment: Active in Rats

Originator

Marrian, G.F.
1
Curator's Comment: In 1929 a substance-pregnandiol-was isolated by Marrian' from the urine of pregnant women

Approval Year

Unknown
139594
Targets

Targets

Primary TargetPharmacologyConditionPotency
Agonist
2678
 0.85 µM [EC50]
Activator
1430
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Effect of maternal intrahepatic cholestasis on fetal steroid metabolism.
1974 Jun
Effect of oestradiol-17beta and progesterone on the metabolism of [1,2(-3)H] progesterone by the rabbit endometrium and myometrium.
1976 Apr 15
Urinary excretion of 5beta-pregnane-3alpha,20alpha,21-triol in human gestation.
1978 Mar
Patents

Patents

20030104360
1

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
In the presence of 100 uM pregnanediol, bilirubin glucuronidation of G71R-UGT1A1 was reduced to 51% of WT.
Name Type Language
PREGNANDIOL
JAN   WHO-DD  
Systematic Name English
NSC-47462
Code English
PREGNANEDIOL
MI  
Systematic Name English
DIOL
Brand Name English
PREGNANEDIOL [MI]
Common Name English
5.BETA.-PREGNANE-3.ALPHA.,20.ALPHA.-DIOL
Common Name English
(3.ALPHA.,5.BETA.,20.ALPHA.)-PREGNANE-3,20-DIOL
Common Name English
PREGNANE-3,20-DIOL, (3.ALPHA.,5.BETA.,20S)-
Systematic Name English
3.ALPHA.,20.ALPHA.-DIHYDROXY-5.BETA.-PREGNANE
Common Name English
Pregnandiol [WHO-DD]
Common Name English
NSC-1612
Code English
PREGNANDIOL [JAN]
Common Name English
Classification Tree Code System Code
LOINC 34358-2
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
LOINC 14885-8
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
LOINC 82895-4
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
LOINC 2832-4
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
LOINC 2834-0
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
LOINC 15091-2
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
LOINC 34359-0
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
LOINC 2833-2
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
CFR 21 CFR 862.1605
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
CFR 21 CFR 862.1430
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
LOINC 82894-7
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
NCI_THESAURUS C776
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
Code System Code Type Description
EPA CompTox
DTXSID6046218
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
PRIMARY
NSC
47462
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
PRIMARY
WIKIPEDIA
PREGNANEDIOL
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
PRIMARY
FDA UNII
JR3JD1Y22C
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
PRIMARY
NCI_THESAURUS
C82314
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
PRIMARY
NSC
1612
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
PRIMARY
MESH
D011276
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
PRIMARY
MERCK INDEX
m9115
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
PRIMARY Merck Index
CAS
80-92-2
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
PRIMARY
EVMPD
SUB15006MIG
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
PRIMARY
PUBCHEM
219833
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
PRIMARY
ChEMBL
CHEMBL269897
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
PRIMARY
ECHA (EC/EINECS)
201-313-7
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
PRIMARY
SMS_ID
100000078869
Created by admin on Fri Dec 15 16:17:45 GMT 2023 , Edited by admin on Fri Dec 15 16:17:45 GMT 2023
PRIMARY
SUBSTANCE RECORD
Structure of PREGNANDIOL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966